Manufacturing guide
How to Choose a Tablet Manufacturer
A tablet manufacturer's real fit depends on formulation support, process routes, tooling, press and coating capability, quality controls, packaging and market documentation.
Short answer
Choose a tablet manufacturer against your product's risks, not the broad claim “tablet manufacturing.” The facility must be able to develop or receive the formula, select and control the process route, compress it with suitable tooling, test the relevant attributes and package it for the intended shelf life and market.
Searches for tablet manufacturers in India or any other country still require facility-level diligence. Geography does not replace evidence of technical and quality fit.
Evidence guide: Published evidence — supported by the linked technical source. · Development guidance — a practical decision or testing framework, not a universal specification. · Manufacturer-specific — depends on the selected site, equipment and commercial arrangement. · Product-specific validation — must be demonstrated with the actual formula, process, pack and market.
Start with product and process fit
Ask whether the site supports direct compression, dry granulation, wet granulation and coating where your formulation may require them. Capability should include the specific equipment scale, material controls and team experience—not merely a route named on a website.
The manufacturer should explain how it will assess flow, compactability, lubricant sensitivity, segregation and the compression defects relevant to the formula.
Press, tooling and coating
Confirm press type and scale, tablet-weight and geometry range, tooling standard, available shapes, score or embossing review, in-process controls and containment constraints. For coating, clarify pan scale, coating types, colour control, weight-gain control, defect handling and whether the core can tolerate the process.
Custom tooling ownership, storage, maintenance and replacement should be explicit in the agreement.
Quality evidence
Review legal entity, manufacturing site, applicable authorization, quality-system scope, supplier qualification, specifications, master records, deviations, change control, validation approach, cleaning, traceability, laboratory arrangements, batch documentation and complaints/recall.
For tablets, ask how weight, thickness, mechanical strength, friability, disintegration, dissolution where required, assay and uniformity are controlled. Requirements remain product- and market-specific.
Packaging and shelf-life fit
A strong compression operation may still lack the bottle, blister or high-barrier configuration your product needs. Confirm actual line and component capability, integrity controls, desiccant handling, coding, aggregation where relevant, and the stability program. Use the tablet packaging guide to define the question.
Commercial fit
Compare development work, process trials, tooling, MOQ basis, raw-material sourcing, packaging procurement, testing, stability, lead-time milestones, payment, formula ownership, change control and re-order conditions. Review tablet MOQ, cost and lead time on a normalized scope.
Questions that test the claim
Ask what formulation evidence is needed before quoting; why the proposed process is appropriate; what defects are most likely; what commercial speed is realistic; how scale-up will be demonstrated; what happens if compression fails; which tests are in-house; which entity and facility hold the relevant approvals; and what is explicitly excluded.
Clear limitations are a positive signal. Universal confidence without product review is not.
Sources and evidence boundaries
- Partheniadis, Terzi and Nikolakakis, “Finite Element Analysis and Modeling in Pharmaceutical Tableting,” Pharmaceutics 14 (2022): 673. Full text
- Jakubowska and Ciepluch, “Blend Segregation in Tablets Manufacturing and Its Effect on Drug Content Uniformity—A Review,” Pharmaceutics 13 (2021): 1909. Full text
- Markl and Zeitler, “A Review of Disintegration Mechanisms and Measurement Techniques,” Pharmaceutical Research 34 (2017): 890–917. Full text
- ICH, “Q1A(R2): Stability Testing of New Drug Substances and Products.” Official guideline
This framework does not rank or endorse manufacturers. Facility capability, certification and market suitability require current documentary and project-specific confirmation.